Assessing the efficacy and safety of sequential intravesical gemcitabine and docetaxel – does time from transurethral resection of bladder tumour to induction matter?
BJU International | March 22, 2025 | Volume: 136 | Issue: 1 | Pages: 42-44
10.1111/bju.16716
| PMID 40118650